New Alzheimer’s Medications
Dr Emer MacSweeney, CEO and Medical Director at Re:Cognition Health shared her excitement with the Daily Express about the groundbreaking new Alzheimer’s drugs that are now available […]
New Alzheimer’s Medications
Dr Emer MacSweeney, CEO and Medical Director at Re:Cognition Health shared her excitement with the Daily Express about the groundbreaking new Alzheimer’s drugs that are now available […]
Re:Cognition Health Brings Groundbreaking Alzheimer’s Treatment Kisunla™ to Private Patients
Re:Cognition Health is proud to announce the launch of Kisunla™ (donanemab), a revolutionary Alzheimer’s treatment, for private patients at our specialist clinics. This follows the success of […]
Sign Up for Our Newsletter
Get our latest news, insights, and expert knowledge
"*" indicates required fields